September 24th- Live from IMS 2026: Can the gut microbiome influence the efficacy and toxicity of CAR-T cells — and could we eventually manipulate it to improve patient outcomes?
September 22nd- MaaT013 fecal microbiotherapy modulates key gastro-intestinal and immunological processes involved in GvHD pathogenesis in vitro and in vivo
August 6th- Beyond the webinar- Preventing Relapse After Allogeneic Transplantation in High-Risk Myeloid Malignancies: Are We Entering the Era of Precision Post-Transplant Care?
